This site is intended for healthcare professionals

FDA advises Lipocine that it is working towards action on the NDA for Tlando to treat hypogonadism on or about 30 November 2020.

Read time: 1 mins
Last updated:9th Nov 2020
Published:9th Nov 2020
Condition: Testosterone Deficiency
Type: drug
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest